Board of Directors

The Board approves strategic directions, organisation structure, policies and implementation processes. Directors observe corporate governance principles and a code of conduct in keeping with the Corporations Act and the Australian Charities and Not-for-profits Commission governance standards.

All other Board committees support and report to the Board. It meets regularly and reports to the Members of the Company on whose behalf it makes decisions. The CEO is appointed by and reports to the Board.

(See our glossary of medical and professional acronyms for details of qualifications).

Board Members


Associate Professor Jeremy Millar Professor Jeremy Millar

Specialist Radiation Oncologist at Alfred Health. Monash University and Alfred Health Director of Radiation Oncology Research. He is a Non-Executive Director of Cancer Council Australia, Council member of the Faculty of Radiation Oncology, RANZCR, and a Monash University Professor, working in cancer clinical quality registries, particularly in prostate cancer. Jeremy is a member and a past Chair of Cancer Council Victoria’s Clinical Network. He has also served as Director of the Southern Melbourne Integrated Cancer Service (2006-7). He was initially appointed to Cancer Council Victoria Board in 2013 and was appointed to the role of Chair on 31 October 2018.

Mrs Fiona Green
Deputy Chair

Fiona has had a 25+ years career in technology and the implementation of digital transformation strategies and initiatives. Fiona holds a number of Non-Executive Director roles, having held numerous executive roles including at DXC Technology and Telstra. 

Mr David Gibbs Mr David Gibbs, AM
BCom (Melb), FCA, FAICD, TEP

A business strategist and adviser, David has over 35 years' experience in business, sharpening his passion for Corporate Governance and the identification and management of risk. He’s a committed supporter for a number of community-based and youth organisations, including a foundation director of the Melbourne Community Foundation. David also served as the Chairman of the Victorian State Council of Chartered Accountants Australia & New Zealand. Joining the Cancer Council Executive Committee in 2008, David continues in the role of Director and has been a member of the Company’s Finance, Risk & Audit Committee since 1 October 2015.

Professor Jane Visvader
BSc (Hons) PhD Adelaide

A scientist specialising in breast cancer research who works for the Walter and Eliza Hall Institute in Melbourne. She is the joint head of the Breast Cancer Laboratory with Professor Geoff Lindeman. She was a joint recipient of the GSK Award for Research Excellence for outstanding contribution to breast cancer research. Jane's most recent award is the 2014 Royal Society of Victoria Research Medal for Scientific Excellence in Biomedical & Health Sciences. She has been a Director since 2015.

Michele Williams
BA (Hons)

Michele is a General Counsel with over 20 years’ experience, in two leading global law firms, in-house at an international management investment company and in-house at an Australian manufacturing business with global clients. She has a long history of involvement with Cancer Council Victoria, serving on the Tuxedo Junction Ball committee since 2001.  Michele is also the Chair of the Finance, Risk and Audit Committee (FRAC).

Professor Gail Risbridger

Professor Risbridger is an NH&MRC Senior Principal Research Fellow. She holds a PhD & has over 30 years’ experience as one of Australia's leading authorities in prostate cancer and Men’s Health. She leads Prostate Cancer Research at Monash University and at the Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre (VCCC) where her laboratory is an internationally recognised research team of scientists and clinicians working on prostate cancer and Andrology related projects. Her laboratories represent a commitment to leading & exemplifying excellence in research with a record of world class achievements in research, research translation, expertise, vision, supervision & mentoring. She has >256 publications that have made significant and highly original contributions of major importance, influence, and of significant benefit to health and medical research. She also holds the position of Deputy Dean, Special Projects, within the Faculty Medicine, Nursing and Health Sciences at Monash University.

Ben Solomon Professor Ben Solomon

A medical oncologist at the Peter MacCallum Cancer Centre, he is a Group Leader of the Molecular Therapeutics and Biomarkers Laboratory in the Research Division. He has an interest in translational lung cancer research and completed a PhD investigating the mechanisms by which EGFR inhibition enhance the effects of radiation, and undertook subsequent postdoctoral studies at the University of Colorado. Professor Solomon returned to Peter Mac in 2006, where he now practices as a medical oncologist with a research focus on clinical and translational research in lung cancer and head and neck cancer. His clinical trial work focuses on the identification of novel therapies for lung cancer.

Jayne Dullard Ms Jayne Dullard
BA (Hons), GAICD

Jayne is a strategic communications and engagement specialist. Following a 20-year career in journalism, including as Senior Producer of the Jon Faine program on ABC Radio, she has held roles as Chief Executive of national government and media relations firms, CPR Pty Ltd, and Executive Director Communications at The Royal Children's Hospital. Jayne established her own business in 2017, working in sectors including healthcare and tertiary education to help clients build reputation, embed change and lift performance. She is a graduate of the Australian Institute of Company Directors and former Deputy Chair of Melbourne Writers Festival.

Professor Jon Emery Professor Jon Emery

Prof Jon Emery is the Herman Professor of Primary Care Cancer Research at the University of Melbourne, and the Victorian Comprehensive Cancer Centre Primary Care Research and Education Lead. He is also Director of the Cancer Australia Primary Care Collaborative Cancer Clinical Trials Group (PC4), and a Visiting Research Fellow at the Department of Public Health and Primary Care, University of Cambridge. He studied medicine at Cambridge and Oxford, trained in general practice in Bath, and obtained his DPhil at Oxford on computer decision support to assess cancer risk in general practice. At the University of Melbourne, he leads a research program focused on the role of primary care across the cancer continuum including prevention, early diagnosis and survivorship, aiming to improve the integration of health services. He leads a parallel program of cancer research between Melbourne and Cambridge on cancer screening, risk assessment and early diagnosis. He sits on several national and international advisory committees related to cancer early detection and survivorship, and cancer research. He has worked closely with Cancer Council Victoria on several projects related to the early detection of cancer and has been a member of their clinical network since 2013.

Kathryn Bellion Kathryn Bellion

Kathryn is an executive HR practitioner, business and people leader. Having practised law early in her career, she realised her professional interest was to work through people and Kathryn has held a number of senior HR leadership roles in professional and financial services, and in health and medical research with the Murdoch Children’s Research Institute and Victorian Clinical Genetics Services.

Kathryn’s non-executive director experience includes Holmesglen Institute where she is also a member of the People, Culture & Remuneration Committee, and with University College as Deputy President and Chair of the Scholarship Committee and member of the Governance Committee.

All Directors and Board committee members receive no remuneration for their services. They may be reimbursed for reasonable costs and expenses incurred in connection with Board and Board committee activities.